Not logged inAssociation of body mass index and serum markers with immune-related adverse events in lung cancer patients receiving immune checkpoint inhibitors
Liu, Zhenzhen; Diao, Yuzhu; Chen, Shuchen; Jin, Meizi; Hong, Chengyu; Li, Jielin; Li, Fei; Li, Ting; Meng, Lihui; Wang, Duo; Zhu, Xinjiang; Li, Xiaoling .png)
Share.png)
SaveShare Save Share Save Share Save Share Save Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/ chemoimmunotherapy: A multi-center cohort studyHong, Zhinuan; Xie, Shuhan; Xu, Hui; Ke, Sunkui; Liu, Wenyi; Huang, Shijie; Chen, Shuchen; Xie, Jinbiao; Xu, Jinxin; Kang, Mingqiang Share Save Share Save Share Save Share Save Prognostic value of ground-glass opacity on computed tomography for patients with pathological stage IA3 lung adenocarcinoma: a multicenter retrospective cohort studyChen, Chao; Xu, Shao-Jun; Du, Xiao-Qiang; Tu, Jia-Hua; Yan, Ren-He; Chen, Hui; Divisi, Duilio; Um, Sang-Won; Luo, Yun-Fan; Zhang, Zhi-Fan; You, Cheng-Xiong; Yu, Shao-Bin; Chen, Shu-Chen Share Save Share Save Share Save Share Save Share Save Share Save Prognostic value of inflammatory nutritional scores in locally advanced esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multicenter study in ChinaXu, Jinxin; Hong, Zhinuan; Cai, Yingjie; Chen, Zhen; Lin, Jingping; Yuan, Xi; Chen, Shuchen; Xie, Jinbiao; Kang, Mingqiang; Ke, Sunkui Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
